hnRNP BI expression in benign and malignant lung disease

Journal of Pathology

Volumn 200, Issue 1, 2003, Pages 88-94

  Snead, David R J ^a   Perunovic, B ^a   Cullen, N ^a   Needham, M ^b   Dhillon, D P ^b   Satoh, H ^c   Kamma, H ^c  

^a University Hospitals of Coventry   (United Kingdom)

^b UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Benign lung disease; hnRNP B1; Lung cancer; Premalignant; Screening

Indexed keywords

RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN B1; UNCLASSIFIED DRUG; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-B1;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ASPERGILLOSIS; BENIGN TUMOR; BRONCHIOLITIS; BRONCHUS MUCOSA; BRONCHUS MUCUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; FIBROSING ALVEOLITIS; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SARCOIDOSIS; LUNG SARCOMA; LUNG TUBERCULOSIS; LYMPH NODE; MALE; MINERAL DUST; ORGANIZING PNEUMONIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESPIRATORY EPITHELIUM; SJOEGREN SYNDROME; SQUAMOUS CELL CARCINOMA; SYSTEMIC SCLEROSIS; TISSUE SECTION; ADENOCARCINOMA; CARCINOSARCOMA; LUNG DISEASE; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CARCINOSARCOMA; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0037649051     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1292     Document Type: Article

References (18)

1. Izaurralde E, Jarmolowski A, Beisel C, Mattaj I, Drefuss G, Fischer U. A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export. J. Cell Biol 1997; 137: 27-35.
2. Mayeda A, Munroe SH, Caceres JF, Krainer AR. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J 1994; 13: 5483-5495.
3. Tockman MS. Clinical detection of lung cancer progression markers. J Cell Biochem Suppl 1996; 25: 177-184.
4. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997; 3: 2237-2246.
5. Qiao, YL, Tockman MS, Li L, et al. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China. Cancer Epidemiol Biomarkers Prev 1997; 6: 893-900.
6. Kozu T, Henrich B, Schafer KP. Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1. Genomics 1995; 25: 365-371.
7. Fielding P, Turnbull L, Prime W, Walshaw M, Field JK. Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 1999; 5: 4048-4052.
8. Kamma H, Horiguchi H, Wan L, et al. Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp Cell Res 1999; 246: 399-411.
9. Hamasaki M, Kamma H, Wu W, et al. Expression of hnRNP B1 in four major histological types of lung cancers. Anticancer Res 2001; 21: 979-984.
10. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 1999; 59: 1404-1407.
11. Goto Y, Sueoka E, Chiba H, Fujiki H. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn J Cancer Res 1999; 90: 1358-1363.
12. Matsuyama S, Goto Y, Sueoka N, et al. Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jpn J Cancer Res 2000; 91: 658-663.
13. Zhou J, Mulshine JL, Ro JY, et al. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res 1998; 4: 1631-1640.
14. Zhou J, Jensen SM, Steinberg SM, Mulshine JL, Linnoila RI. Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer 1996; 14: 85-97.
15. Man YG, Martinez A, Avis IM, et al. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am J Respir Cell Mol Biol 2000; 23: 636-645.
16. Satoh H, Kamma H, Ishikawa H, et al. Expression of hnRNP A2/B1 proteins in human cancer cell lines. Int J Oncol 2000; 16: 763-767.
17. Tockman M, Gupta P, Myers J. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988; 6: 1685-1693.
18. Montuenga LM, Zhou J, Avis I, et al. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development. Am J Respir Cell Mol Biol 1998; 19: 554-562.